Back to search
FDAFDA · Food and drugs·Recall number D-0172-2025

Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03. packaged in an Airless pump pack

Published January 8, 2025 · Recall initiated: December 10, 2024

Summary

FDA records drug Class II recall D-0172-2025, published January 8, 2025 and initiated December 10, 2024. Recalling firm: VIONA PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: 2760 packs; Lot: Lots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Crystallization

What to do

Voluntary: Firm initiated · Letter

Get an email if DAPSONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DAPSONE
Manufacturer
VIONA PHARMACEUTICALS INC
Distributor
US Nationwide
Lot
Lots T400514, Exp Date 02/2026 & T400808, Exp Date 03/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-03. packaged in an Airless pump pack recalled?

Yes. FDA published recall D-0172-2025 on January 8, 2025. Reported hazard: Crystallization

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DAPSONE.